Generic drug
Glyburide / metformin price, strengths & recalls
Pharmacies pay $5.70 for 30 tablets of Glyburide / metformin 5 mg / 500 mg tablet this week, and from $4.82 to $5.70 across its 2 priced strengths and forms. 9 manufacturers make it. Its official label last changed on August 20, 2026.
Generic- Fair cash price
- $17.06
- Strengths
- 2
- Makers
- 9
- Updated
- Nov 11
Glyburide / metformin price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 1.25 mg / 250 mg tablet | Not priced this week | |||
| 2.5 mg / 500 mg tablet | $0.1606 | $4.82 / 30 tablets | ||
| 5 mg / 500 mg tablet | $0.1899 | $5.70 / 30 tablets | ||
Supply status: shortages & recalls
What people paid for Glyburide / metformin
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLETS. GLYBURIDE and METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 2000
WARNING: LACTIC ACIDOSIS
Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metformin-associated lactic acidosis was characterized by elevated blood lactate levels (>5 mmol/Liter), anion gap acidosis (without evidence of ketonuria or ketonemia), an increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL [see Warnings and Precautions (5.1)].
Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic impairment, and mitochondrial diseases [see Warnings and Precautions (5.1)].
Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided [see Dosage and Administration (2.3), Contraindications (4) and Warnings and Precautions (5.1)].
If metformin-associated lactic acidosis is suspected, immediately discontinue glyburide and metformin hydrochloride and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended [see Warnings and Precautions (5.1)].
WARNING: LACTIC ACIDOSIS
See full prescribing information for complete boxed warning.
Post-marketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. Symptoms include malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Laboratory abnormalities included elevated blood lactate levels, anion gap acidosis, increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL. (5.1)
Risk factors include renal impairment, concomitant use of certain drugs, age ≥ 65 years old, radiological study with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, hepatic impairment, and mitochondrial diseases. Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information. (5.1)
If lactic acidosis is suspected, discontinue glyburide and metformin hydrochloride and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended. (5.1)
Recent major changes (as listed on the label)
Boxed Warning 03/2026
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Generic makers
- 2 approved generic applications on the market
Glyburide / metformin questions
How much does glyburide / metformin cost without insurance?
Pharmacies pay about $5.70 for 30 tablets of glyburide / metformin 5 mg / 500 mg tablet ($0.1899 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $17.06. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is glyburide / metformin in shortage?
No shortage is reported for glyburide / metformin right now. We check the national shortage list every day.
Has glyburide / metformin been recalled?
No recalls are on record for glyburide / metformin.
When did the glyburide / metformin label last change?
The official label was last updated on August 20, 2026 (version 106). See what changed.
Talk about glyburide / metformin
No comments yet. Questions, tips, what worked for you - start the conversation.